A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators by Song Chen (69646)

“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”

A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators by Song Chen (69646)

“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”

A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators by Song Chen (69646)

“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”

A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators by Song Chen (69646)

“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”

A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators by Song Chen (69646)

“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”

DataSheet1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.pdf by Heather A. Ogana (11774297)

“…A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

DataSheet1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.docx by Heather A. Ogana (11774297)

“…A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

The effects of pre-administrated PPG, BCA or NaHS on rat blood pressure. by Chufan Sun (3390608)

DataSheet1_Butanol as a major product during ethanol and acetate chain elongation.docx by Aide Robles (11161125)

“…We used semi-batch bioreactors (0.16 L serum bottles) fed with a range of ethanol concentrations (100–800 mM C), a constant concentration of acetate (50 mM C), and an initial total gas pressure of ∼112 kPa. …”

Table 1_Impact of the COVID-19 pandemic on prehospital emergency medical service: a scoping review.docx by Hannah Richter (2579002)

“…The quantitative data on changes in EMS operations show a more significant overall decrease (mean: −12.2%, standard deviation: 24.7%, minimum: −72% to maximum: 56%).…”

Verification of the knock out efficiency of <i>VPREB1</i> gene in myeloma cells by immunofluorescence. by Mai Khaled (9962968)

Supplementary Material for: Deep Brain Stimulation of the Globus Pallidus Internus In a Child With Refractory Dystonia Due To L2-Hydroxyglutaric Aciduria by Alamri A. (18308008)

Basis Set Limit CCSD(T) Energies for Extended Molecules via a Reduced-Cost Explicitly Correlated Approach by Mihály Kállay (1512775)

“…The new method can provide, e.g., reaction energies and barrier heights well within chemical accuracy for molecules with more than 40 atoms within a few days using a few dozen processor cores, and calculations with 50+ atoms are still feasible. …”

Data_Sheet_1_Research protocol for bridging research, accurate information and dialogue (BRAID)—clinical trials: a mixed-methods study of a community-based intervention to improve... by Damara N. Gutnick (19676227)

Frequency trajectories of iSNVs that fluctuated (Top) and their positions on the genome (Bottom) (patients A-I). by Lele Zhao (532080)

“…<p>The inclusion criterion was iSNVs that changed from below 50% at Baseline (i.e., 0 days post baseline), to above 50% at PT12 (12 weeks post treatment), and decreased to below 50% at PT24 (24 weeks post treatment). …”

Image2_Fever management in children and insights into fever of unknown origin: a survey among Italian pediatricians.jpeg by Elena Chiappini (304802)

“…Compared to what participants reported for the treatment of non-prolonged fever, a significant decrease in the prescription of paracetamol as first-choice drug in children with FUO was observed (80.5%; P < 0.0001). …”

Image1_Fever management in children and insights into fever of unknown origin: a survey among Italian pediatricians.jpeg by Elena Chiappini (304802)

“…Compared to what participants reported for the treatment of non-prolonged fever, a significant decrease in the prescription of paracetamol as first-choice drug in children with FUO was observed (80.5%; P < 0.0001). …”

Heat map of phenotypes associated with COVID-19 outcomes. by Rebecca J. Song (8849639)

Table_2_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.XLSX by Jan Vollert (5099921)

“…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”

Table_1_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.xlsx by Jan Vollert (5099921)

“…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”